By Vrinda Manocha
Wed Sep 4, 2013 10:54am EDT
(Reuters) – Rockwell Medical Inc said its lead experimental drug met the main goal of improving hemoglobin levels in its final late-stage trial among adult patients with chronic kidney disease.
Rockwell shares rose 14…
Rockwell Medical’s iron deficiency drug succeeds in final study
No comments:
Post a Comment